Reshape Lifesciences Pharmaceuticals Healthcare: Ken Research
ReShape Lifesciences Inc (RSLS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

ReShape Lifesciences Inc (RSLS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile


  • Products Id :- GDPH12407D
  • |
  • Pages: 35
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

ReShape Lifesciences Inc (ReShape) formerly known as EnteroMedics Inc is a medical device company that develops minimally invasive medical devices to treat obesity and metabolic diseases. The company develops vBloc, a therapy used in the treatment of gastrointestinal and neurometabolic diseases; and ReShape Balloon System, which is indicated for weight reduction when used in conjunction with diet and exercise, in obese patients and obesity-related comorbid conditions. ReShape's vBloc therapy is a rechargeable neuroregulator that is implanted subcutaneously and attached to the vagal nerve. The company's product vBloc is a minimally invasive therapy that does not alter patient's anatomy. ReShape is headquartered in San Clemente, California, the US.

ReShape Lifesciences Inc (RSLS)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

ReShape Lifesciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

ReShape Lifesciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

ReShape Lifesciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

ReShape Lifesciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

ReShape Lifesciences Inc, Medical Devices Deals, 2012 to YTD 2018 9

ReShape Lifesciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

ReShape Lifesciences Inc, Pharmaceuticals & Healthcare, Deal Details 11

Venture Financing 11

Reshape Medical Raises USD38 Million in Series D Financing 11

Reshape Medical Raises Additional USD3.5 Million in Venture Financing 13

Reshape Medical Raises Additional USD1.25 Million in Venture Financing 14

Equity Offering 15

ReShape Lifesciences to Raise USD6 Million in Private Placement of Shares and Warrants 15

EnteroMedics Raises USD20 Million in Public Offering of Units 17

Debt Offering 19

EnteroMedics Raises USD6.2 Million in Third Tranche of Private Placement of 7% Notes Due 2017 19

EnteroMedics Raises USD11 Million in Second Tranche of Private Placement of 7% Notes Due 2017 20

EnteroMedics Raises USD1.5 Million in First Tranche of Private Placement of 7% Notes Due 2017 21

Acquisition 22

EnteroMedics Acquires BarioSurg 22

ReShape Lifesciences Inc-Key Competitors 23

ReShape Lifesciences Inc-Key Employees 24

ReShape Lifesciences Inc-Locations And Subsidiaries 25

Head Office 25

Other Locations & Subsidiaries 25

Recent Developments 26

Financial Announcements 26

May 14, 2018: ReShape Lifesciences Announces Record Revenue for First Quarter 2018 26

Apr 02, 2018: ReShape Lifesciences Announces Fourth Quarter and Year End 2017 Financial Results 27

Feb 01, 2018: ReShape Lifesciences Reports Preliminary Fourth Quarter and Full Year 2017 Revenue 28

Aug 08, 2017: EnteroMedics Announces Second Quarter 2017 Financial Results 29

May 16, 2017: EnteroMedics Announces First Quarter 2017 Financial Results 30

Mar 07, 2017: EnteroMedics Reports Fourth Quarter 2016 Financial Results 31

Product News 33

Feb 09, 2017: EnteroMedics Announces Publication of Three-Year Data from vBloc Diabetic Patient Study in Journal of Diabetes and Obesity 33

Jan 05, 2017: EnteroMedics Announces vBloc Neurometabolic Therapy Now Available at MedStar Health and Roper St. Francis 34

Appendix 35

Methodology 35

About GlobalData 35

Contact Us 35

Disclaimer 35

List of Figures

ReShape Lifesciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

ReShape Lifesciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

ReShape Lifesciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

ReShape Lifesciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

ReShape Lifesciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

ReShape Lifesciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

ReShape Lifesciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

ReShape Lifesciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

ReShape Lifesciences Inc, Medical Devices Deals, 2012 to YTD 2018 9

List of Tables

ReShape Lifesciences Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

ReShape Lifesciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

ReShape Lifesciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

ReShape Lifesciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

ReShape Lifesciences Inc, Deals By Therapy Area, 2012 to YTD 2018 8

ReShape Lifesciences Inc, Medical Devices Deals, 2012 to YTD 2018 9

ReShape Lifesciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Reshape Medical Raises USD38 Million in Series D Financing 11

Reshape Medical Raises Additional USD3.5 Million in Venture Financing 13

Reshape Medical Raises Additional USD1.25 Million in Venture Financing 14

ReShape Lifesciences to Raise USD6 Million in Private Placement of Shares and Warrants 15

EnteroMedics Raises USD20 Million in Public Offering of Units 17

EnteroMedics Raises USD6.2 Million in Third Tranche of Private Placement of 7% Notes Due 2017 19

EnteroMedics Raises USD11 Million in Second Tranche of Private Placement of 7% Notes Due 2017 20

EnteroMedics Raises USD1.5 Million in First Tranche of Private Placement of 7% Notes Due 2017 21

EnteroMedics Acquires BarioSurg 22

ReShape Lifesciences Inc, Key Competitors 23

ReShape Lifesciences Inc, Key Employees 24

ReShape Lifesciences Inc, Subsidiaries 25

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

ReShape Lifesciences Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license

Single User License
USD 250 INR 16863
Site License
USD 500 INR 33725
Corporate User License
USD 750 INR 50588

NEWSLETTER BY CATEGORY




Testimonials

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...



Ken Research, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com